BioPorto AS (2P4) Financial Statements
2 Followers
BioPorto AS Financial Overview
BioPorto AS's market cap is currently $66.90M. The company's EPS TTM is $0.01; its P/E ratio is 75.13; BioPorto AS has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Mar 24 | Dec 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 40.29M | $ 36.24M | $ 30.96M | $ 28.97M | $ 24.25M |
| Gross Profit | $ 28.01M | $ 24.53M | $ 20.18M | $ 19.04M | $ 15.04M |
| Operating Income | $ -86.09M | $ -75.45M | $ -60.16M | $ -77.88M | $ -65.25M |
| EBITDA | $ -84.56M | $ -70.53M | $ -57.89M | $ -76.49M | $ -58.47M |
| Net Income | $ -82.12M | $ -68.24M | $ -56.33M | $ -75.92M | $ -57.11M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 54.89M | $ 59.66M | $ 66.40M | $ 81.79M | $ 45.52M |
| Total Assets | $ 93.18M | $ 96.01M | $ 89.81M | $ 108.64M | $ 81.25M |
| Total Debt | $ 7.52M | $ 11.19M | $ 7.25M | $ 10.64M | $ 13.03M |
| Net Debt | $ -47.37M | $ -48.47M | $ -59.15M | $ -71.15M | $ -32.49M |
| Total Liabilities | $ 30.17M | $ 28.23M | $ 29.65M | $ 38.42M | $ 35.29M |
| Stockholders' Equity | $ 63.01M | $ 67.78M | $ 60.16M | $ 70.22M | $ 45.96M |
| Cash Flow | |||||
| Free Cash Flow | $ -77.07M | $ -83.93M | $ -55.49M | $ -52.96M | $ -64.97M |
| Operating Cash Flow | $ -77.07M | $ -83.58M | $ -55.46M | $ -52.48M | $ -64.58M |
| Investing Cash Flow | $ 1.27M | $ 1.19M | $ -277.00K | $ -503.00K | $ -412.00K |
| Financing Cash Flow | $ 71.94M | $ 75.47M | $ 40.79M | $ 88.70M | $ 1.10M |
Currency in DKK
